Patient Safety Movement Foundation’s Mid-Year Meeting Charts Course for Global Patient Safety Initiatives in 2024
The Patient Safety Movement Foundation (PSMF) convened its annual Mid-Year Event to discuss safety challenges in the healthcare system that result in millions of preventable deaths around the world. Keynote addresses and roundtable discussions with renowned patient safety experts in a variety of fields focused on macro-level strategies to create a safer healthcare system with zero preventable harm.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240126619652/en/
Patient Safety Movement Foundation Founder Joe Kiani speaks about the road ahead in global efforts to eliminate preventable patient harm at the PSMF's annual Mid-Year Event. (Photo: Business Wire)
PSMF’s Mid-Year Event invites patient safety thought leaders and advocates, hospital administrators and clinical executives, medical technology executives, major healthcare system payers, patients and their families, and government officials from around the world to review best practices and to chart a course of action for the year.
A keynote by Carol Peden, MD, Co-Chair of the Right Care Initiative, discussed lessons learned from the implementation of evidence-based strategies, including data transparency, and ways to reduce racial and socio-economic disparities in healthcare. Another keynote from David C. Stockwell, MD, the Chief Medical Officer at Johns Hopkins Children’s Center, examined next steps in applying the recommendations of the recent PCAST report to President Biden on the urgent need to addresses widespread preventable harms at U.S. hospitals. Albert Wu, MD, Director at Johns Hopkins Center for Health Services and Outcomes Research, discussed the importance of “just culture” and creating a blame-free culture in which individuals are able to report errors without fear of punishment.
Joe Kiani, Founder of the Patient Safety Movement Foundation, stated, “From day one, we’ve worked to break the silos across the entire healthcare ecosystem to develop solutions informed by all stakeholders, including patients, and with multidisciplinary expertise. The mid-year meeting this year looked at solutions that will help us reach zero preventable harm faster. Momentum is everything. We see a clear pathway toward eliminating preventable medical errors, but we all have a part to play. We need to take action out of kindness.”
“We have an enormous opportunity to save lives around the world,” stated Dr. Mike Durkin, Chair of the Patient Safety Movement Foundation. “It’s now time to bounce back from the impact of the pandemic, during which we learned firsthand of the dangers to patients and healthcare workers. We now need to maintain our momentum to reduce harm and work ceaselessly and collaboratively in all healthcare settings. This year, the World Health Organization will focus on diagnostic safety. We must continue to listen to our patients, their families, and healthcare workers and provide them a platform so that they feel safe in telling their stories without fear.”
“We can have a safer healthcare system today, but we all need to make it a priority,” stated Dr. Michael Ramsay, Chief Executive Officer for the Patient Safety Movement Foundation. “We also need to demand transparency and access to real data from our healthcare providers. I am encouraged by the passion of the meeting attendees and believe 2024 will be a pivotal year for patient safety.”
“This year marks the 25th anniversary of the ‘To Err Is Human’ report,” stated Sanaz Massoumi, Chief Operating Officer for the Patient Safety Movement Foundation. “We now clearly know that practicing evidence-based medicine prevents patient harm, and there is no question that it saves millions of lives and billions of dollars. We hope to partner with more healthcare institutions in 2024. We also hope to empower patients and patient advocates.”
This year’s meeting also featured a presentation by Michael Millenson, President of Health Quality Advisors, LLC, who shared why he believed progress has been slow and what needs to be done to accelerate change and transform our healthcare system. Also presenting today were Dr. Neelam Dhingra, who heads the World Health Organization’s Transformative Flagship Initiative; Dr. Edward Kelley, Chief Global Health Officer of ApiJect; and Dr. Howard Hu, Chair and Professor of Population and Public Health Sciences of the University of Southern California.
Panel recommendations included:
- Board and C-suite’s role in patient safety
- Resilience in healthcare
- Engaging the patient and patient families
- Pediatric safety
- Diagnostic safety
The presentations and roundtable discussions at the Mid-Year Event laid the groundwork for the PSMF’s two-day 11th Annual World Patient Safety, Science & Technology Summit scheduled for later this year, on September 6–7, 2024. For more information, updates, and to register for the Summit, please visit https://psmf.org/summits/11th-annual-world-patient-safety-science-technology-summit/.
ABOUT THE PATIENT SAFETY MOVEMENT FOUNDATION
In 2012, Joe Kiani founded the non-profit Patient Safety Movement Foundation (PSMF) to eliminate preventable medical errors in hospitals. His team worked with patient safety experts from around the world to create Actionable Evidence-Based Practices (AEBP) that address the top challenges. The AEBP are available without charge to hospitals online. Hospitals are encouraged to make a formal commitment to ZERO preventable deaths, and healthcare technology companies are asked to sign the Open Data Pledge to share their data so that predictive algorithms that can identify errors before they become fatal can be developed. The Foundation's annual World Patient Safety, Science & Technology Summit brings together all stakeholders, including patients, healthcare providers, medical technology companies, government employers, and private payers. The PSMF was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare. For more information, please visit psmf.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240126619652/en/
Contact information
Patient Safety Movement Foundation
Irene Mulonni, irene@mulonni.com | (858) 859-7001
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 20:00:00 EEST | Press release
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 202525.4.2025 15:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago, IL, from April 25–30. “At AACR we will be presenting data from early-stage programs across our oncology portfolio, including for patients with myeloproliferative neoplasms, ovarian cancer and other solid tumors,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These data will guide our approach as we advance our pipeline and seek to transform the treatment landscape for patients with cancer and myeloproliferative neoplasms.” Abstracts accepted for presentation at AACR include: Mini Symposium INCB177054 INCB177054: A Novel, Potent, Orally Bioavailable DGKα/ζ Dual Inhibitor Enhances T-Cell Function and Demonstrates Potent Antitumor Activity (Session Title: Novel Antitumor Agents. April 28, 4:50 p.m. – 5:05 p.m. ET (3:50 p.m. – 4:05 p.m. CT). Abstract #
SLB Announces First-Quarter 2025 Results; Remains Committed to Return a Minimum of $4 Billion to Shareholders in 202525.4.2025 13:50:00 EEST | Press release
SLB (NYSE: SLB) today announced results for the first-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423635499/en/ The exterior of the SLB headquarters in Houston, Texas. First-Quarter Results (Stated in millions, except per share amounts) Three Months EndedChange Mar. 31, 2025 Dec. 31, 2024 Mar. 31, 2024 Sequential Year-on-year Revenue $8,490 $9,284 $8,707 -9% -3% Income before taxes - GAAP basis $1,063 $1,387 $1,357 -23% -22% Income before taxes margin - GAAP basis 12.5% 14.9% 15.6% -241 bps -306 bps Net income attributable to SLB - GAAP basis $797 $1,095 $1,068 -27% -25% Diluted EPS - GAAP basis $0.58 $0.77 $0.74 -25% -22% Adjusted EBITDA* $2,020 $2,382 $2,057 -15% -2% Adjusted EBITDA margin* 23.8% 25.7% 23.6% -186 bps 18 bps Pretax segment operating income* $1,556 $1,918 $1,649 -19% -6% Pretax segment operating margin* 18.3% 20.7% 18.9% -232 bps -60 bps Net income attributable to SLB, excluding charges &
Corona, The World’s Most Valuable Beer Brand 1 , Announces Its 100-Year Anniversary with Global Celebration25.4.2025 11:00:00 EEST | Press release
Today, Corona proudly celebrates its 100-year anniversary, a remarkable milestone for the iconic brand that has been synonymous with the beach and enjoyed by consumers worldwide for the past century. Since 1925, Corona has cultivated a deep association with the beach; fully embodying a lifestyle connected to nature and relaxation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425804516/en/ Corona 100 This Is Living Since 1925 In honor of the occasion, Corona invites everyone to live their “beach side” – a.k.a. their best side – at top-tier beach locations across the globe. The Corona 100 platform includes a film highlighting 100 years of beach culture, a definitive list of the top 100 beaches in the world to visit, and a signed multi-year sponsorship of a renowned concert at Copacabana Beach in Rio de Janeiro — all offering people across the globe opportunities to connect with their beach side. “For 100 years, Corona has
Ant Group Unveils New Recruitment Initiative for Top AI Talents, Ramping Up AI Innovation Efforts25.4.2025 10:28:00 EEST | Press release
Ant Group today unveiled Plan A, a new recruitment initiative to attract top artificial intelligence researchers, reinforcing its commitment to accelerating AI research and development under the “AI First” corporate strategy. Operating within the framework of Ant Star—Ant Group’s year-round campus recruitment program—Plan A specifically targets AI talents who are ambitious, adaptable, altruistic, and analytical. Outstanding graduates from universities worldwide with STEM majors are encouraged to apply for Plan A. Relevant fields include computer science, software engineering, artificial intelligence, cybersecurity, information and telecommunication engineering, mathematics, statistics, and other emerging interdisciplinary areas. To better foster the development of technological innovators in this new AI era, Plan A offers candidates comprehensive support and resources, including unrestricted access to AI hardware and tailored career paths that allow for significant research freedom. Ad
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom